Novo Holdings A/s - Net Worth and Insider Trading
Novo Holdings A/s Net Worth
The estimated net worth of Novo Holdings A/s is at least $1.5 Billion dollars as of 2024-06-18. Novo Holdings A/s is the 10% Owner of Arcellx Inc and owns about 4,016,878 shares of Arcellx Inc (ACLX) stock worth over $216 Million. Novo Holdings A/s is the 10% Owner of iRhythm Technologies Inc and owns about 2,124,448 shares of iRhythm Technologies Inc (IRTC) stock worth over $203 Million. Novo Holdings A/s is also the 10% Owner of CoLucid Pharmaceuticals Inc and owns about 3,156,563 shares of CoLucid Pharmaceuticals Inc (CLCD) stock worth over $147 Million. Besides these, Novo Holdings A/s also holds Harmony Biosciences Holdings Inc (HRMY) , Edgewise Therapeutics Inc (EWTX) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , Morphic Holding Inc (MORF) , Disc Medicine Inc (IRON) , AnaptysBio Inc (ANAB) , Checkmate Pharmaceuticals Inc (CMPI) , Inogen Inc (INGN) , Flexion Therapeutics Inc (FLXN) , Nkarta Inc (NKTX) , Apollo Endosurgery Inc (APEN) , Cyteir Therapeutics Inc (CYTT) , Inozyme Pharma Inc (INZY) , Metagenomi Inc (MGX) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Verve Therapeutics Inc (VERV) , Milestone Pharmaceuticals Inc (MIST) , Bolt Biotherapeutics Inc (BOLT) , Corvus Pharmaceuticals Inc (CRVS) , Spruce Biosciences Inc (SPRB) , Galecto Inc (GLTO) , Aligos Therapeutics Inc (ALGS) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) . Details can be seen in Novo Holdings A/s's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Novo Holdings A/s has not made any transactions after 2024-05-10 and currently still holds the listed stock(s).
Transaction Summary of Novo Holdings A/s
Novo Holdings A/s Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Novo Holdings A/s owns 41 companies in total, including Praxis Precision Medicines Inc (PRAX) , Eargo Inc (EAR) , and Aligos Therapeutics Inc (ALGS) among others .
Click here to see the complete history of Novo Holdings A/s’s form 4 insider trades.
Insider Ownership Summary of Novo Holdings A/s
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRAX | Praxis Precision Medicines Inc | 2020-10-15 | 10 percent owner |
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
ALGS | Aligos Therapeutics Inc | 2020-10-20 | 10 percent owner |
![]() | ![]() | 2021-02-18 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2024-03-21 | 10 percent owner |
![]() | ![]() | 2020-08-21 | 10 percent owner |
![]() | ![]() | 2022-02-25 | 10 percent owner |
![]() | ![]() | 2021-01-28 | 10 percent owner |
![]() | ![]() | 2020-07-14 | 10 percent owner |
![]() | ![]() | 2020-07-08 | 10 percent owner |
![]() | ![]() | 2019-11-25 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2019-07-22 | 10 percent owner |
![]() | ![]() | 2019-06-28 | 10 percent owner |
![]() | ![]() | 2018-09-28 | 10 percent owner |
![]() | ![]() | 2017-10-12 | 10 percent owner |
![]() | ![]() | 2017-08-25 | 10 percent owner |
![]() | ![]() | 2017-08-21 | 10 percent owner |
![]() | ![]() | 2017-07-26 | 10 percent owner |
![]() | ![]() | 2017-06-14 | 10 percent owner |
![]() | ![]() | 2016-12-15 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2016-10-31 | 10 percent owner |
![]() | ![]() | 2016-10-25 | 10 percent owner |
![]() | ![]() | 2016-09-09 | 10 percent owner |
![]() | ![]() | 2016-07-11 | 10 percent owner |
![]() | ![]() | 2015-06-22 | 10 percent owner |
![]() | ![]() | 2014-11-05 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2021-03-01 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2014-08-12 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2014-06-23 | 10 percent owner & other: See Remarks |
![]() | ![]() | 2014-05-13 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2014-03-19 | 10 percent owner & other: SEE REMARKS |
![]() | ![]() | 2021-10-26 | 10 percent owner |
![]() | ![]() | 2023-06-23 | 10 percent owner |
![]() | ![]() | 2022-07-13 | 10 percent owner |
![]() | ![]() | 2023-07-20 | 10 percent owner |
![]() | ![]() | 2022-09-14 | 10 percent owner |
![]() | ![]() | 2022-02-08 | 10 percent owner |
![]() | ![]() | 2020-11-02 | 10 percent owner |
![]() | ![]() | 2021-06-21 | 10 percent owner |
![]() | ![]() | 2024-05-10 | 10 percent owner |
![]() | ![]() | 2023-06-28 | 10 percent owner |
Novo Holdings A/s Latest Holdings Summary
Novo Holdings A/s currently owns a total of 37 stocks. Among these stocks, Novo Holdings A/s owns 4,016,878 shares of Arcellx Inc (ACLX) as of February 8, 2022, with a value of $216 Million and a weighting of 14.63%. Novo Holdings A/s owns 2,124,448 shares of iRhythm Technologies Inc (IRTC) as of October 25, 2016, with a value of $203 Million and a weighting of 13.78%. Novo Holdings A/s also owns 3,156,563 shares of CoLucid Pharmaceuticals Inc (CLCD) as of September 9, 2016, with a value of $147 Million and a weighting of 9.95%. The other 34 stocks Harmony Biosciences Holdings Inc (HRMY) , Edgewise Therapeutics Inc (EWTX) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , Morphic Holding Inc (MORF) , Disc Medicine Inc (IRON) , AnaptysBio Inc (ANAB) , Checkmate Pharmaceuticals Inc (CMPI) , Inogen Inc (INGN) , Flexion Therapeutics Inc (FLXN) , Nkarta Inc (NKTX) , Apollo Endosurgery Inc (APEN) , Cyteir Therapeutics Inc (CYTT) , Inozyme Pharma Inc (INZY) , Metagenomi Inc (MGX) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Verve Therapeutics Inc (VERV) , Milestone Pharmaceuticals Inc (MIST) , Bolt Biotherapeutics Inc (BOLT) , Corvus Pharmaceuticals Inc (CRVS) , Spruce Biosciences Inc (SPRB) , Galecto Inc (GLTO) , Aligos Therapeutics Inc (ALGS) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) have a combined weighting of 61.64% among all his current holdings.
Latest Holdings of Novo Holdings A/s
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACLX | Arcellx Inc | 2022-02-08 | 4,016,878 | 53.75 | 215,907,193 |
IRTC | iRhythm Technologies Inc | 2016-10-25 | 2,124,448 | 95.75 | 203,415,896 |
CLCD | CoLucid Pharmaceuticals Inc | 2016-09-09 | 3,156,563 | 46.53 | 146,859,094 |
HRMY | Harmony Biosciences Holdings Inc | 2020-08-21 | 4,409,803 | 29.37 | 129,515,914 |
EWTX | Edgewise Therapeutics Inc | 2022-09-14 | 6,071,703 | 17.37 | 105,465,481 |
RETA | Reata Pharmaceuticals Inc | 2017-06-14 | 592,794 | 172.36 | 102,173,974 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 2,031,562 | 47.99 | 97,494,660 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 2,445,147 | 33.00 | 80,689,851 |
TBRA | Tobira Therapeutics Inc | 2016-07-13 | 1,875,905 | 42.09 | 78,956,841 |
MORF | Morphic Holding Inc | 2019-06-28 | 2,645,446 | 26.12 | 69,099,050 |
IRON | Disc Medicine Inc | 2023-06-28 | 1,090,772 | 44.86 | 48,932,032 |
ANAB | AnaptysBio Inc | 2017-08-21 | 1,936,604 | 23.38 | 45,277,802 |
CMPI | Checkmate Pharmaceuticals Inc | 2022-02-25 | 2,161,990 | 10.50 | 22,700,895 |
INGN | Inogen Inc | 2021-03-01 | 2,759,320 | 7.27 | 20,060,256 |
FLXN | Flexion Therapeutics Inc | 2015-06-22 | 2,133,131 | 9.12 | 19,454,155 |
NKTX | Nkarta Inc | 2020-07-14 | 2,793,865 | 5.67 | 15,841,215 |
APEN | Apollo Endosurgery Inc | 2017-07-26 | 1,301,842 | 10.00 | 13,018,420 |
CYTT | Cyteir Therapeutics Inc | 2023-07-20 | 3,522,136 | 3.01 | 10,601,629 |
INZY | Inozyme Pharma Inc | 2021-01-28 | 2,194,379 | 4.60 | 10,094,143 |
MGX | Metagenomi Inc | 2024-02-13 | 1,739,175 | 4.21 | 7,321,927 |
RPHM | Reneo Pharmaceuticals Inc | 2023-06-23 | 3,330,337 | 1.65 | 5,495,056 |
IOBT | IO Biotech Inc | 2024-05-10 | 4,429,449 | 1.23 | 5,448,222 |
ETTX | Entasis Therapeutics Holdings Inc | 2018-09-28 | 2,181,843 | 2.19 | 4,778,236 |
VERV | Verve Therapeutics Inc | 2021-06-21 | 793,265 | 5.27 | 4,180,507 |
MIST | Milestone Pharmaceuticals Inc | 2019-11-25 | 2,434,470 | 1.39 | 3,383,913 |
BOLT | Bolt Biotherapeutics Inc | 2022-07-13 | 3,703,991 | 0.75 | 2,792,068 |
CRVS | Corvus Pharmaceuticals Inc | 2020-07-08 | 1,389,498 | 1.93 | 2,681,731 |
SPRB | Spruce Biosciences Inc | 2024-03-21 | 2,550,000 | 0.65 | 1,664,895 |
GLTO | Galecto Inc | 2020-11-02 | 2,497,791 | 0.51 | 1,261,384 |
ALGS | Aligos Therapeutics Inc | 2020-10-20 | 2,614,563 | 0.47 | 1,231,982 |
GRTX | Galera Therapeutics Inc | 2021-02-18 | 2,459,021 | 0.09 | 221,312 |
EAR | Eargo Inc | 2020-10-20 | 44,354 | 2.57 | 113,990 |
UTRS | Minerva Surgical Inc | 2021-10-26 | 102,857 | 0.00 | 103 |
CMPI | Cold Metal Products Inc | 2020-08-11 | 2,170,100 | 0.00 | 0 |
KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | 0 | 11.82 | 0 |
HTGMQ | HTG Molecular Diagnostics Inc | 2017-08-25 | 0 | 0.00 | 0 |
ISEE | IVERIC bio Inc | 2016-12-15 | 0 | 39.95 | 0 |
Holding Weightings of Novo Holdings A/s
Novo Holdings A/s Form 4 Trading Tracker
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Arcellx Inc is the acquisition of 833,333 shares on February 8, 2022, which cost Novo Holdings A/s around $13 Million.
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 0 transactions in iRhythm Technologies Inc (IRTC) over the past 5 years. The most-recent trade in iRhythm Technologies Inc is the acquisition of 100,000 shares on October 25, 2016, which cost Novo Holdings A/s around $2 Million.
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 0 transactions in CoLucid Pharmaceuticals Inc (CLCD) over the past 5 years. The most-recent trade in CoLucid Pharmaceuticals Inc is the acquisition of 100,000 shares on September 9, 2016, which cost Novo Holdings A/s around $2 Million.
More details on Novo Holdings A/s's insider transactions can be found in the Insider Trading History of Novo Holdings A/s table.Insider Trading History of Novo Holdings A/s
- 1
Novo Holdings A/s Trading Performance
GuruFocus tracks the stock performance after each of Novo Holdings A/s's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Novo Holdings A/s is 3.33%. GuruFocus also compares Novo Holdings A/s's trading performance to market benchmark return within the same time period. The performance of stocks bought by Novo Holdings A/s within 3 months outperforms 15 times out of 37 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Novo Holdings A/s's insider trading performs compared to the benchmark.
Performance of Novo Holdings A/s
Novo Holdings A/s Ownership Network
Ownership Network List of Novo Holdings A/s
Ownership Network Relation of Novo Holdings A/s
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Novo Holdings A/s Owned Company Details
What does Praxis Precision Medicines Inc do?
Who are the key executives at Praxis Precision Medicines Inc?
Novo Holdings A/s is the 10 percent owner of Praxis Precision Medicines Inc. Other key executives at Praxis Precision Medicines Inc include Chief Executive Officer Marcio Souza , Chief Financial Officer Timothy Edwin Kelly , and Principal Accounting Officer Lauren Mastrocola .
Praxis Precision Medicines Inc (PRAX) Insider Trades Summary
Over the past 18 months, Novo Holdings A/s made no insider transaction in Praxis Precision Medicines Inc (PRAX). Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 80,002 shares made by Marcio Souza , a net purchase of 50,000 shares made by Dean J Mitchell , and a net purchase of 14,500 shares made by Jill Desimone .
In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 10,167 shares were bought by its insiders, resulting in a net purchase of 10,167 shares.
Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Praxis Precision Medicines Inc Insider Transactions
Novo Holdings A/s Mailing Address
Above is the net worth, insider trading, and ownership report for Novo Holdings A/s. You might contact Novo Holdings A/s via mailing address: Tuborg Havnevej 19, Hellerup G7 2900.